Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Patrick J. Heron received 5,778 Arcutis Biotherapeutics, Inc. shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 9, 2026
On Jun 5, 2026, Patrick J. Heron (Director) received 5,778 Arcutis Biotherapeutics, Inc. shares as an award, leaving 32,213 shares. Filed Jun 9, 2026 (Form 4).
- Awarded
- 5,778 shares
- Holding after
- 32,213 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 5,778 | 32,213 | Direct |